Clinical Trials Logo

Clinical Trial Summary

Monitoring of inflammatory substances (such as interleukins, CRP, albumine), and markers of organ dysfunction (such as creatinine, proenkephaline, amylase, troponine, IFABP and lactate) during elective liver resection. The study also includes monitoring of hemodynamic parameters, blood loss and postoperative complications. Results are to be used för power calculation for future trials.


Clinical Trial Description

During hepatic surgery, blood and urine samples will be obtained at 3 times during surgery, at 3 h after resection of liver, at 24 h after resection of liver and at post operative day 2, and subsequntly analyzed for the above mentioned substances. Routine labs will be monitored until patient is discharged from hospital. During surgery, hemodynamic parameters will be monitored by Picco calculations. Urine output and blood loss will be registred. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03878615
Study type Observational
Source Sahlgrenska University Hospital, Sweden
Contact
Status Completed
Phase
Start date November 10, 2018
Completion date April 2, 2019

See also
  Status Clinical Trial Phase
Completed NCT01919034 - Evaluating the Relationship of Morphine Consumption and Pain-related Molecules in Hepatic Surgical Patients